Loading
A phase 3 trial of Porfimer sodium in Biliary tract cancer and Gallbladder cancer, run by University College, London, completed.
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery is a phase 3 interventional study registered as NCT00513539 by University College, London, with 92 participants recorded, started 2007-07 and reaching its primary completion in 2009-12. Interventions recorded: porfimer sodium, biliary stenting. Conditions recorded: Extrahepatic Bile Duct Cancer, Gallbladder Cancer.
Linked to the drug Porfimer sodium because the registry names it among its interventions and Biliary tract cancer and Gallbladder cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Porfimer sodium and the tag pipeline.
Shares Biliary tract cancer (cholangiocarcinoma) and the tag pipeline.
Shares Porfimer sodium and the tag pipeline.
Shares Biliary tract cancer (cholangiocarcinoma) and the tag pipeline.
Shares Biliary tract cancer (cholangiocarcinoma) and the tag pipeline.
Shares Biliary tract cancer (cholangiocarcinoma) and the tag pipeline.
Shares Biliary tract cancer (cholangiocarcinoma), Gallbladder cancer and the tag pipeline.
Shares Biliary tract cancer (cholangiocarcinoma) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/